1. Introduction {#sec1}
===============

Exogenously added and endogenously produced H~2~S affects many physiological and pathological processes \[[@B1]--[@B3]\]. Accumulating evidence supports the involvement of H~2~S in the regulation of cardiovascular homeostasis \[[@B4]\]. It has mostly beneficial effects during oxidative stress by reacting with reactive oxygen and nitrogen species, i.e., hydrogen peroxide (H~2~O~2~), superoxide anion radical (O~2~^·−^), hypochlorite (HOCl), or peroxynitrite (ONOO^−^) \[[@B5]--[@B8]\]. However, several effects of H~2~S on cells are toxic \[[@B9]--[@B11]\].

Selenium (Se) is a relatively rare but an essential trace element for humans, plants, and microorganisms. Se, which exerts multiple and complex effects on human health, is known as an antioxidant due to its presence in 25 selenoproteins in the form of selenocysteine amino acid. Both beneficial and detrimental effects of Se deficiency and/or supplementation are well known. The biological effects of Se compounds (selenite, selenate, selenocysteine, and selenomethionine) on cardiac oxidative damage, heart disease, cancer prevention, immunity, diabetes, neuroregeneration, or dementia have been reported \[[@B12]--[@B17]\]. However, the beneficial effect of Se supplementation for men\'s health is still a controversial issue \[[@B18]--[@B23]\]. Selenite, which is a common Se supplement, is considered as a promising anticarcinogen \[[@B24]--[@B26]\]. It can induce apoptosis in cancer cells through the production of reactive oxygen species (ROS) leading to oxidative stress \[[@B27], [@B28]\]. However, Se compounds were also found to damage DNA in healthy cells \[[@B29]\] and therefore may not be considered as a suitable protective agent against cancer and/or other chronic diseases. Actually, they can cause or advance some kinds of cancers \[[@B30], [@B31]\]. The exact mechanisms of the beneficial and toxic effects of Se are not yet fully understood, giving rise to further uncertainty about its potential use in nutrition supplements and/or clinical treatment.

Se and H~2~S are present in living organisms, and each one has beneficial and/or toxic effects through its interaction mostly with ROS \[[@B1], [@B2], [@B30]--[@B33]\]. However, the biological effects of products of the H~2~S/selenite interaction are not yet known, namely, their involvement in the production and/or inhibition of ROS, reaction with DNA, or influence on cardiovascular system. Therefore, we have studied the effects of products of the H~2~S/selenite interaction on O~2~^·−^ and ^**·**^cPTIO radicals, DNA cleavage, tension of isolated aortic rings, and rat blood pressure (BP). We found that the products have significant biological effects that differ from those caused by H~2~S or by selenite on their own. These results may contribute to the understanding of possible coupled biological effects of H~2~S and Se.

2. Material and Methods {#sec2}
=======================

2.1. Chemicals {#sec2.1}
--------------

### 2.1.1. Selenium Compounds {#sec2.1.1}

Stock solutions of sodium selenite (Na~2~SeO~3~, 10 or 40 mmol L^−1^, Merck K34993707-542 or Sigma 214485), selenium tetrachloride (SeCl~4~, 10 mmol L^−1^, Aldrich 323527), and sodium selenate (Na~2~SeO~4~, 10 mmol L^−1^, Sigma S0882) were prepared freshly in deionized H~2~O, stored at 23°C, and used within 5 h. Na~2~SeO~3~ dissociates in solution to yield mostly H~2~SeO~3~ at acidic pH, HSeO~3~^−^ at neutral pH, and SeO~3~^2−^ at alkaline pH. For simplicity, the term SeO~3~^2−^ is employed as representative expression to encompass the total mixture of these different (de)protonation states.

### 2.1.2. Hydrogen Peroxide {#sec2.1.2}

Hydrogen peroxide (H~2~O~2~) (14.7 mol L^−1^; Sigma-Aldrich 85321), according to a particular experiment, was diluted in H~2~O or in 100 mmol L^−1^ sodium phosphate buffer, supplemented with 200 or 50 *μ*mol L^−1^ DTPA, pH 7.4, 37°C before application.

### 2.1.3. Radicals {#sec2.1.3}

5-*tert*-butoxycarbonyl-5-methyl-1-pyrroline-*N*-oxide (BMPO, 100 mmol L^−1^, Dojindo B568-10, Japan) was dissolved in deionized H~2~O, stored at -80°C, and used after thawing. 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (^·^cPTIO, 10 mmol L^--1^, Cayman 81540 or Sigma C221) was dissolved in deionized H~2~O and was stored at -20°C for several weeks.

### 2.1.4. Sulfide {#sec2.1.4}

Na~2~S (100 mmol L^−1^ stock solution, Dojindo SB01, Japan) was dissolved in argon degassed deionized H~2~O, stored at −80°C, and used immediately after thawing. Na~2~S dissociates in aqueous solution and reacts with H^+^ to yield H~2~S, HS^−^, and a trace of S^2−^. We use the term H~2~S to describe the total mixture of H~2~S, HS^−^, and S^2−^ forms. The stock concentration was checked by UV-VIS spectroscopy: by the absorbance of 1000x diluted stock solution at 230 nm (*ε*~230 nm~ = 7700 mol^−1^ L cm^−1^, diluted by deionized water) and also by the reduction of 100 *μ*mol L^−1^ DTNB by 2000x diluted stock solution (1 H~2~S molecule generates 2 TNB^−^ equivalents, *ε*~412 nm~ = 14,100 mol^−1^ L cm^−1^, measured in 1 mmol L^−1^ phosphate buffer), according to Nagy et al. \[[@B34]\].

### 2.1.5. Buffers {#sec2.1.5}

100 mmol L^−1^ sodium phosphate buffer supplemented with 100 *μ*mol L^−1^ diethylenetriaminepentaacetic acid (DTPA), pH 6.5, 7.0, 7.4, 8.0, and 9.0, 37°C, was employed for UV-VIS experiments. 50 and 25 mmol L^−1^ sodium phosphate buffer, supplemented with 100 and 50 *μ*mol L^−1^ DTPA, pH 7.4, 37°C, was used for electron paramagnetic resonance (EPR) and plasmid DNA (pDNA) cleavage studies, respectively.

2.2. UV-VIS of ^·^cPTIO {#sec2.2}
-----------------------

To obtain 1 mL of the working solution, 10 or 100 *μ*L of stock solution of the compounds studied was added to the appropriate volume (990 or 900 *μ*L, respectively) of 100 mmol L^−1^ sodium phosphate buffer (at given pH, 37°C) containing the final concentrations of 100 *μ*mol L^−1\ **·**^cPTIO and 100 *μ*mol L^−1^ DTPA. UV-VIS absorption spectra (900-190 nm) were recorded every 30 s for 20 to 40 min with a Shimadzu 1800 (Kyoto, Japan) spectrometer at 37°C. The ^**·**^cPTIO extinction coefficient of 920 mol^−1^ L cm^−1^ at 560 nm was used. The reduction of the ^**·**^cPTIO radical was determined as the decrease of the absorbance at 560 nm (absorption maximum of ^**·**^cPTIO in VIS range) or at 358 nm after subtracting the absorbances at 730 or at 420 nm, respectively \[[@B5], [@B35]\].

To study the involvement of O~2~ in the H~2~S/SeO~3~^2−^-induced reduction of the ^·^cPTIO radical, 10 mmol L^−1^ Na~2~S in H~2~O, 10 mmol L^−1^ Na~2~SeO~3~ in H~2~O, and 102 *μ*mol L^−1\ ·^cPTIO in the 100 mmol L^--1^ sodium phosphate buffer, supplemented with 100 *μ*mol L^−1^ DTPA (pH 7.4; 37°C), were deaerated with argon for 10 min at 37°C. The compounds were mixed in a closed UV-cuvette, and the UV-VIS spectra were recorded. The O~2~ concentration in the deaerated samples was 3-5%, confirmed with an oxygen electrode (OXELP, SYS-ISO2, WPI, USA). In all UV-VIS experiments, H~2~O was used as a blank.

2.3. EPR of the ^·^BMPO Adducts {#sec2.3}
-------------------------------

To study the ability of H~2~S/SeO~3~^2−^ to scavenge the O~2~^·−^ radical or its derivatives produced in DMSO/KO~2~ solution, sample preparation and EPR measurements were conducted in accordance with previously reported protocols \[[@B5]\]. The solution (final concentrations) of BMPO (20 mmol L^−1^), DTPA (100 *μ*mol L^−1^) in sodium phosphate buffer (50 mmol L^−1^, pH 7.4) was incubated for 1 min at 37°C; an aliquot of the compound was added, followed by saturated KO~2~/DMSO solution (10% *v*/*v* DMSO/final buffer) 3 s later. The sample was mixed for 5 s and transferred to a standard cavity aqueous EPR flat cell. The first EPR spectrum was recorded 2 min after the addition of KO~2~/DMSO solution at 37°C. The sets of individual EPR spectra of the ^·^BMPO spin adducts were recorded as 15 sequential scans, each 42 s, with a total time of 11 min. Each experiment was repeated at least twice. EPR spectra of the ^·^BMPO spin adducts were measured on a Bruker EMX spectrometer, X-band \~9.4 GHz, 335.15 mT central field, 8 mT scan range, 20 mW microwave power, 0.1 or 0.15 mT modulation amplitude, 42 s sweep time, 20.48 ms time constant, and 20.48 ms conversion time at 37°C. Intensities of the ^·^BMPO adducts in the EPR spectra were reproducible, when the KO~2~/DMSO stock solution was stored at 5°C for 1 day or at 23 ± 1°C for 4 h.

2.4. Plasmid DNA Cleavage {#sec2.4}
-------------------------

pDNA cleavage assay with the use of pBR322 plasmid (New England BioLabs Inc., N3033L) was performed as reported previously \[[@B5], [@B36]\]. In this assay, all samples contained 0.2 *μ*g pDNA in sodium phosphate buffer (25 mmol L^−1^ sodium phosphate, 50 *μ*mol L^−1^ DTPA, pH 7.4, 37°C). After addition of compounds, the resulting mixtures were incubated for 30 min at 37°C. All concentrations listed in the section were final in the samples. After incubation, the reaction mixtures were subjected to 0.6% agarose gel electrophoresis. Samples were electrophoresed in TBE buffer (89 mmol L^−1^ Tris, 89 mmol L^−1^ boric acid, and 2 mmol L^−1^ EDTA) at 5.5 V cm^−1^ for 2 h; gels were stained with GelRed™ Nucleic Acid Gel Stain and photographed using a UV transilluminator. Integrated densities of all pBR322 forms in each lane were quantified using the TotalLab TL100 image analysis software to estimate pDNA cleavage efficiency (Nonlinear Dynamic Ltd., USA).

2.5. Guide for the Use and Care of Laboratory Animals {#sec2.5}
-----------------------------------------------------

### 2.5.1. Isolated Thoracic Aorta {#sec2.5.1}

Procedures were performed in accordance with the Institutional Guidelines of the Ethical Committee on the Ethics of Procedures in Animal, Clinical and other Biomedical Experiments (permit number: EC/CEM/2017/4) of the Institute of Normal and Pathological Physiology, Centre of Experimental Medicine and were approved by the State Veterinary and Food Administration of the Slovak Republic and by an Ethical Committee according to the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes, Directive 2010/63/EU of the European Parliament. The Institute of Normal and Pathological Physiology provided veterinary care.

### 2.5.2. Rat Blood Pressure {#sec2.5.2}

All procedures were approved by the State Veterinary and Food Administration of the Slovak Republic (No.: Ro-1545/15-221) according to the guidelines from Directive 2010/63/EU of the European Parliament. Experiments were carried out according to the guidelines laid down by the animal welfare committee of the Institute of Normal and Pathological Physiology of the Slovak Academy of Sciences and conformed to the principles and regulations, as described in the editorial by Grundy \[[@B37]\].

2.6. Functional Study of Isolated Thoracic Aorta {#sec2.6}
------------------------------------------------

Normotensive Wistar Kyoto (WKY) rats (307 ± 4.3 *g*) were killed by decapitation after a brief anesthetization with CO~2~, and the thoracic aorta was isolated as described in our previous study \[[@B38]\]. The changes in isometric tension were measured by the electromechanical transducers (FSG-01, MDE, Budapest, Hungary). The resting tension of 1 g was applied to each ring and maintained throughout a 45 to 60 min of equilibration period until stress relaxation no longer occurred. Changes in thoracic aorta tension were followed by noradrenaline (NA; 1 *μ*mol L^−1^) precontracted arterial rings after a stable plateau was achieved.

2.7. Functional Study of Rat Blood Pressure {#sec2.7}
-------------------------------------------

Male Wistar rats (*n* = 10; 350 ± 40 g) were from the Department of Toxicology and Laboratory Animal Breeding at Dobra Voda, Slovak Academy of Sciences, Slovakia. The rats were housed under a 12 h light-12 h dark cycle, at a constant humidity (45-65%) and temperature (20-22°C), with free access to standard laboratory rat chow and drinking water. The *Institute of Experimental Pharmacology* and *Toxicology*, Centre of Experimental Medicine, Slovak Academy of Sciences, provided veterinary care. The tranqualizer xylazine (Rometar) was purchased from Zentiva (Czech Republic), and the anesthetic combination of tiletamine+zolazepam (Zoletil 100) was acquired from Virbac (France). All other chemicals were purchased from Sigma-Aldrich. Experiments were carried out as previously described \[[@B39]\]. Rats were anesthetized with Zoletil 100 (tiletamine+zolazepam, 80 mg kg^−1^, i.p.) and Rometar (xylazine, 5 mg kg^−1^, i.p.). During the anesthesia, BP, heart rate, and reflex responses to mechanical stimuli were monitored. The animals were under anesthesia during the whole experiment and were euthanized with an overdose of Zoletil *via* jugular vein at the end of the surgical procedure. All experiments were supervised and performed under the same experimental conditions.

2.8. Blood Pressure Measurement {#sec2.8}
-------------------------------

The right jugular vein was cannulated to administer compounds under anesthesia as described above. The left arteria carotis communis was cannulated for inserting the fiber optic microcatheter pressure transducers (FISO LS 2F Harvard Apparatus, USA). The analog signal was digitalized at 10 kHz, filtered at 1 kHz, and recorded by DEWESoft 6.6.7 (GmbH, Austria). The signal was evaluated 5 s before and 10 min after compound administration. After stabilization of BP (10-20 min), the compounds were administered into the right jugular vein as a bolus of 500 *μ*L kg^−1^ over 15 s period. The solution of the H~2~S/SeO~3~^2−^ mixture (10/5 in mmol L^−1^) was prepared as follows: to 123.5 *μ*L of 100 mmol L^−1^ phosphate buffer, 100 *μ*mol L^−1^ DTPA, 14 *μ*L of 1 mol L^−1^ HCl was added, followed by 62.5 *μ*L of 40 mmol L^−1^ Na~2~SeO~3~ in 0.9% NaCl, and finally 50 *μ*L of 100 mmol L^−1^ Na~2~S in H~2~O was added. The pH of the buffered mixture was 7.4. The mixture was incubated for 40 ± 10 s at 23°C before i.v. administration. Unbuffered H~2~S/SeO~3~^2−^ mixture (10/5 in mmol L^−1^) was prepared, when 0.9% NaCl was used instead of phosphate buffer and HCl. The pH of the unbuffered mixture was \~11 measured by a pH paper indicator.

2.9. Statistical Analysis {#sec2.9}
-------------------------

Unless otherwise stated, data are represented as the means ± S.E.M. Statistical significance was determined by Student\'s *t*-test or one-way ANOVA followed by the multiple comparison test. Differences between means were considered significant at ^∗^*P* ≤ 0.05. Data analysis and plot construction were carried out using SigmaPlot 12 (Systat Software GmbH).

3. Results {#sec3}
==========

3.1. H~2~S Interacts with Na~2~SeO~3~ and SeCl~4~, but Not with Na~2~SeO~4~, to Form Initial Reactive Intermediate(s), which Reduce the ^·^cPTIO Radical {#sec3.1}
--------------------------------------------------------------------------------------------------------------------------------------------------------

Since the antioxidant properties of H~2~S/SeO~3~^2−^ products are unknown, we have used the ^·^cPTIO radical to study the reducing properties of the products of H~2~S/SeO~3~^2−^ interaction. The ^·^cPTIO radical is stable in aqueous solution, and its formation and reduction can be monitored by the UV-VIS spectrophotometry at 358 or 560 nm. Even in the presence of up to 100 *μ*mol L^−1^ H~2~S or 100-400 *μ*mol L^−1^ SeO~3~^2−^, the absorbance (ABS) of the radical at 358 and 560 nm decreases only by \<7% after 40 min, indicating that neither H~2~S nor SeO~3~^2−^ on its own reduces this radical ([Figure 1](#fig1){ref-type="fig"}). In contrast, once H~2~S (25-100 *μ*mol L^−1^) was added to the ^·^cPTIO/SeO~3~^2−^ (100/2.5-400 *μ*mol L^−1^) mixture, or SeO~3~^2−^ was added to ^·^cPTIO/H~2~S, the absorbances at 358 and 560 nm decreased rapidly over the time (≤30 s), indicating a possible formation of strong reducing agent(s) which fastly and efficiently reduced the ^·^cPTIO radical (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Similar results were obtained when SeCl~4~, but not Na~2~SeO~4~, was used instead of SeO~3~^2−^ (Figures [](#supplementary-material-1){ref-type="supplementary-material"} and [](#supplementary-material-1){ref-type="supplementary-material"}).

The reduction of ^·^cPTIO followed a bell-shaped dependence on the concentration of SeO~3~^2−^ at a constant ^·^cPTIO/H~2~S concentration ([Figure 2(a)](#fig2){ref-type="fig"}), with a maximum radical scavenging activity at an H~2~S : SeO~3~^2−^ ratio of roughly 4 : 1. The ability of H~2~S to reduce ^·^cPTIO in the presence of SeO~3~^2−^ increased with the increasing H~2~S concentration ([Figure 2(b)](#fig2){ref-type="fig"}) and followed also a bell-shaped dependence on pH (Figures [3](#fig3){ref-type="fig"} and [](#supplementary-material-1){ref-type="supplementary-material"}).

If H~2~S and SeO~3~^2−^ were preincubated for different periods of time before the addition to ^·^cPTIO, it clearly resulted in the highest radical scavenging activity, which was subsequently lost over the time ([Figure 4](#fig4){ref-type="fig"}). An H~2~S/SeO~3~^2−^ (100/100 in *μ*mol L^−1^) mixture preincubated for ≥1 min prior to ^·^cPTIO addition did not reduce ^·^cPTIO, demonstrating that later products of the reaction of sulfide with SeO~3~^2−^ could not be responsible for the reduction of the radical and that the relevant active species were formed swiftly, in less than 1 min and have a short lifetime, as recently suggested \[[@B40]\]. Notably, formation of these active early intermediates to reduce ^·^cPTIO was prolonged with the increase of the H~2~S/SeO~3~^2−^ ratio ([Figure 4(e)](#fig4){ref-type="fig"}). At H~2~S/SeO~3~^2−^ concentration of 100/25 in *μ*mol L^−1^ and 5 min preincubation time, the mixture still possessed around 50% potency to reduce ^·^cPTIO ([Figure 4(e)](#fig4){ref-type="fig"}). This timing, once more, accounts for a rapidly formed selenosulfide intermediate as beeing the ultimate responsible for this radical scavenging activity, a species also possibly being sensitive to oxidation over prolonged time periods ([Figure 4](#fig4){ref-type="fig"}).

While the available evidence is in accordance with the formation of HSSeSH as the main reactive species, there are other chalcogen-based candidates which are good reducing agents, namely, hydrogen selenide (H~2~Se), hydroselenide anion (HSe^−^), selenide (Se^2−^), persulfides, and polysulfides (S*~x~*^2--^) \[[@B41]--[@B43]\]. Interestingly, O~2~ does not seem to play a major role in the H~2~S/SeO~3~^2−^-induced reduction of the ^·^cPTIO radical probably due to slower kinetics of interaction of reactants and/or intermediates with O~2~ in comparison to the rate of ^·^cPTIO reduction \[[@B44]--[@B48]\]. Under argon flushed conditions, reduction of the ^·^cPTIO radical was neither enhanced nor suppressed significantly, hence ruling out any major involvement of H~2~Se, as this selenium compound is highly sensitive to O~2~ ([](#supplementary-material-1){ref-type="supplementary-material"}).

3.2. EPR of ^·^BMPO-OOH: The Initial Products of the H~2~S/SeO~3~^2−^ Interaction Also Scavenge Derivatives of Superoxide Anion (O~2~^·--^) Radical {#sec3.2}
---------------------------------------------------------------------------------------------------------------------------------------------------

We aimed to ascertain whether the initial products of the H~2~S/SeO~3~^2−^ interaction are able to scavenge other radicals, i.e., O~2~^·−^ or its derivatives. The interactions with O~2~^·−^ were studied with the EPR spin trap method based on the reaction of this dioxygen radical with BMPO to form the ^·^BMPO-OOH adduct \[[@B49]\]. This assay was chosen due to biological and mechanistical reason; O~2~^·−^ is a simple radical reduced by one-electron transfer.

O~2~^·−^ was dissolved in phosphate buffer (pH 7.4, 37°C) and trapped by BMPO. Under these conditions, the relative intensity of the ^·^BMPO-OOH adduct decreased slowly over the time and was comparable to the values reported under physiological conditions (Figures [5(a1)](#fig5){ref-type="fig"}--[5(a3)](#fig5){ref-type="fig"}) \[[@B49]\]. The addition of SeO~3~^2−^ (25 and 50 *μ*mol L^--1^) did not significantly interfere with the ^·^BMPO-OOH adduct formation, its concentration, and rate of decay (Figures [5(b1)](#fig5){ref-type="fig"}--[5(b3)](#fig5){ref-type="fig"}, [](#supplementary-material-1){ref-type="supplementary-material"}). In contrast, H~2~S (25 and 50 *μ*mol L^−1^) decreased the ^·^BMPO-OOH concentration and increased the rate of the decay, and this "antioxidant" activity of H~2~S was increased further in the presence of SeO~3~^2−^ (more than three times at a 50/25 in *μ*mol L^−1^ H~2~S/SeO~3~^2−^ ratio). This indicates that H~2~S/SeO~3~^2−^ products scavenge O~2~^·−^ and/or its derivatives. The effects of H~2~S/SeO~3~^2−^ were less pronounced when KO~2~/DMSO was added 5 min after addition of H~2~S/SeO~3~^2−^, suggesting that the reducing intermediate had already decomposed at this stage ([Figure 5](#fig5){ref-type="fig"}, [](#supplementary-material-1){ref-type="supplementary-material"}). Similar results were obtained when H~2~S was incubated with SeCl~4~ ([](#supplementary-material-1){ref-type="supplementary-material"}). This indicates that the production of highly active species, products of the H~2~S/SeO~3~^2−^ interaction, was time-dependent: they appeared within a few seconds after addition of SeO~3~^2−^ to the H~2~S solution and their effects diminished after few minutes of interaction.

From our previous studies of O~2~^·−^ reaction with BMPO \[[@B5]\], we assumed that the EPR spectra of the ^·^BMPO adducts were superposed on the ^·^BMPO-OOH/OH radicals with minor contribution from the ^·^BMPO-C radical. Therefore, we simulated the spectra using hyperfine coupling constants for ^·^BMPO-OOH, ^·^BMPO-OH, and ^·^BMPO-C (derived from DMSO) radicals. The means of hyperfine coupling constants used were as follows: ^·^BMPO-OOH1 (black) *a*~*N*~ = 13.30 ± 0.03 *G*, *a*~*H*~ = 11.7 ± 0.1 *G*; ^·^BMPO-OOH2 (red) *a*~*N*~ = 13.24 ± 0.03 *G*, *a*~*H*~ = 9.4 ± 0.1 *G*; ^·^BMPO-OH1 (green) *a*~*N*~ = 13.7 ± 0.3 *G*, *a*~*H*~ = 12.3 ± 0.4 *G*; ^·^BMPO-OH2 (yellow) *a*~*N*~ = 13.6 ± 0.2 *G*, *a*~*H*~ = 15.3 ± 0.1 *G*; and ^·^BMPO-C (blue) *a*~*N*~ = 15.2 ± 0.1 *G*, *a*~*H*~ = 21.5 ± 0.1 *G*. The constants are similar to those reported by Zhao et al. \[[@B49]\]. The simulation revealed that O~2~^·−^ was trapped in the control and in the presence of SeO~3~^2−^ (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}), since the EPR spectra of ^·^BMPO-OOH were only observed. However, ^·^BMPO-OH component was present in the samples containing H~2~S alone or with SeO~3~^2−^ (Figures [5(c)](#fig5){ref-type="fig"}--[5(h)](#fig5){ref-type="fig"}). The results may indicate that H~2~S alone or with SeO~3~^2−^ decomposed ^·^BMPO-OOH to ^·^BMPO-OH and/or ^·^OH was formed as a result of compound presence. Since the first spectrum was recorded 110 ± 15 *s* after sample preparation, we cannot exclude a possibility of trapping of other radicals with lifetimes shorter than 110 s.

3.3. H~2~S/SeO~3~^2−^ Cleaves pDNA {#sec3.3}
----------------------------------

It was of interest to know if the products of the H~2~S/SeO~3~^2−^ interaction have biological effects *in vitro*. Therefore, we investigated the direct effects of H~2~S and SeO~3~^2−^ on the cleavage of pDNA *in vitro* using the Fenton reaction as a positive benchmark control ([Figure 6](#fig6){ref-type="fig"}) \[[@B5]\].

Interestingly, neither H~2~S (1 mmol L^−1^) nor SeO~3~^2−^ (0-1 mmol L^−1^) alone significantly cleaved pDNA. In contrast, SeO~3~^2−^ in a concentration-dependent manner caused damage to DNA in the presence of 1 mmol L^−1^ H~2~S (Figures [6(a1)](#fig6){ref-type="fig"} and [6(a2)](#fig6){ref-type="fig"}). The observed cleavage of DNA caused by SeO~3~^2−^ and H~2~S showed a bell-shaped concentration ratio dependence similar to the one observed in the reduction of the ^·^cPTIO radical. We can suggest that the intermediate responsibility of the action can be a selenopolysulfide with a H~2~S : SeO~3~^2−^ ratio of 4 : 1. In the presence of H~2~O~2~, damage to pDNA by H~2~S occurs also without SeO~3~^2−^, since H~2~O~2~ now takes on the role of SeO~3~^2−^ as an oxidant, with the simultaneous formation of the ^·^OH radicals (Figures [6(b1)](#fig6){ref-type="fig"} and [6(b2)](#fig6){ref-type="fig"}). Further evidence for the involvement of radicals may come from the fact that dimethylsulfoxide (DMSO), a known ^·^OH scavenger \[[@B50], [@B51]\] frequently employed as solvent in biology, is able to interfere with the damage to DNA (Figures [6(c1)](#fig6){ref-type="fig"} and [6(c2)](#fig6){ref-type="fig"}).

3.4. H~2~S/SeO~3~^2−^ Modulates Tension of Isolated Thoracic Aorta {#sec3.4}
------------------------------------------------------------------

As some of our *in vitro* assays indicated an antioxidant activity of the H~2~S/SeO~3~^2−^ mixture, and H~2~S is known to promote relaxation of blood vessels \[[@B52]\], the impact of the H~2~S/SeO~3~^2−^ mixture on the isolated thoracic aorta was examined. The thoracic aorta was precontracted by noradrenaline (NA) (1 *μ*mol L^−1^). After a stabile plateau of the contraction was reached ([Figure 7(a)](#fig7){ref-type="fig"}), SeO~3~^2−^ (100 *μ*mol L^--1^) showed only negligible activity, while Na~2~S (200 *μ*mol L^−1^) significantly relaxed the aortic rings, in agreement with our previous studies \[[@B38]\]. A simultaneous addition of SeO~3~^2−^ (100 *μ*mol L^−1^) and H~2~S (200 *μ*mol L^−1^) resulted once more in a biphasic activity profile, where a minor relaxation was noticed first, followed by a pronounced contraction ([Figure 7](#fig7){ref-type="fig"}). It is supposed that the contraction effect may result also from the antioxidant properties of the mixture, similarly as it has been reported for ascorbate \[[@B53]\].

3.5. H~2~S/SeO~3~^2−^ Modulates Rat Systolic and Pulse Blood Pressure {#sec3.5}
---------------------------------------------------------------------

Since the products of the H~2~S/SeO~3~^2−^ interaction modulated the tension of the thoracic aorta, we subsequently studied whether the products influence blood pressure (BP). Intravenous (i.v.) administration of 5 *μ*mol kg^−1^ SeO~3~^2−^ had only minor effects on BP ([Figure 8(g)](#fig8){ref-type="fig"}). The administration of 10 *μ*mol kg^−1^ of Na~2~S transiently decreased and increased BP (Figures [8(a)](#fig8){ref-type="fig"} and [8(g)](#fig8){ref-type="fig"}), as observed in our previous study \[[@B54]\]. The stock solution of the H~2~S/SeO~3~^2−^ mixture (20/10 in mmol L^−1^) prepared in 0.9% NaCl was colorless and had pH \~ 11. However, when the mixture was prepared in solution with pH 7.4, it had orange color with an absorption maximum at 570 nm ([](#supplementary-material-1){ref-type="supplementary-material"}), indicating formation of the sulfur-selenium complexes \[[@B40]\]. The i.v. administration of the mixture H~2~S/SeO~3~^2−^ (10/5 *μ*mol kg^−1^, pH \~ 7.4), in comparison to H~2~S alone, inhibited both BP decrease and increase (Figures [8(b)](#fig8){ref-type="fig"} and [8(g)](#fig8){ref-type="fig"}). The effects of the mixture were less pronounced at pH \~ 11, being the effects at this pH similar to those observed for H~2~S alone (Figures [8(c)](#fig8){ref-type="fig"} and [8(g)](#fig8){ref-type="fig"}).

The studied compounds influenced pulse BP, as an important parameter of cardiovascular system reflecting arterial stiffness \[[@B55], [@B56]\]. The administration of 5 *μ*mol kg^−1^ SeO~3~^2−^ intravenously had minor effects on pulse BP ([Figure 8(h)](#fig8){ref-type="fig"}). The administration of 10 *μ*mol kg^−1^ of Na~2~S transiently increased and later decreased pulse BP (Figures [8(d)](#fig8){ref-type="fig"} and [8(h)](#fig8){ref-type="fig"}) \[[@B54]\]. The i.v. administration of the mixture H~2~S/SeO~3~^2−^ (10/5 in *μ*mol kg^−1^, pH \~7.4), with comparison to H~2~S alone, eliminated pulse BP increase, but did not affect pulse BP decrease (Figures [8(e)](#fig8){ref-type="fig"} and [8(h)](#fig8){ref-type="fig"}). The effects of the mixture were less pronounced at pH \~ 11 and were similar to those observed for H~2~S alone (Figures [8(f)](#fig8){ref-type="fig"} and [8(h)](#fig8){ref-type="fig"}). The inefficiency of the H~2~S/SeO~3~^2−^ products at pH \~ 11 may be connected with the minor effect of the mixture on the ^·^cPTIO radical reduction at high pH (Figures [3(e)](#fig3){ref-type="fig"} and [3(f)](#fig3){ref-type="fig"}). This may imply that the reduction properties of the mixture could be responsible for their effects on systolic and pulse BP. The results confirm that the products of the H~2~S/SeO~3~^2−^ interaction depend on pH and influence differently the cardiovascular system. In conclusion, the reactivity and biological activity of the H~2~S/SeO~3~^2−^ interaction products prepared at pH 7.4 differ from those of Na~2~S alone.

4. Discussion and Conclusions {#sec4}
=============================

Overall, our studies demonstrate that the two suspected and commonly used "antioxidants," H~2~S and SeO~3~^2−^, are not necessarily typical reducing agents, such as ascorbic acid or tocopherol, when employed on their own. Interestingly, these two chalcogen agents, when added together, rapidly activate each other and form a cascade of considerably more reactive, often reducing species, supposing the involvement of inorganic HSSeSH and polysulfides S*~x~*^2−^, which may account for some of the observed biological actions. The nature of some of these intermediate reactive sulfur and/or selenium species was suggested in a recently published review \[[@B40]\].

The fast and efficient reduction of the ^·^cPTIO radical by H~2~S/SeO~3~^2−^ products (Figures [1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}) supports the notion that the initial intermediate(s) formed by the reaction of H~2~S with SeO~3~^2−^ are responsible for this kind of action. The bell shape and the maximum radical scavenging activity of H~2~S : SeO~3~^2−^ at a ratio of \~4 : 1 ([Figure 2](#fig2){ref-type="fig"}) may indicate the suggested formation of (HSS)~2~Se \[[@B40]\]. The kinetics and efficiency of the H~2~S/SeO~3~^2−^ products to reduce ^·^cPTIO ([Figure 3](#fig3){ref-type="fig"}) point out to complex pH-dependent chemical and radical reactions of the species.

Reactions of H~2~S or polysulfides with SeO~3~^2−^ and/or SeCl~4~ were reported \[[@B40], [@B57]--[@B59]\]. They point towards a rapid conversion of SeO~3~^2−^ and SeCl~4~ to an intermediate, probably HSSeSH, and a subsequent, slower reductive elimination of this intermediate to elemental (mixed) chalcogen particles and disulfides \[[@B40]\]. However, to our knowledge, there is no information about the formation and detection of HSSeSH in cells or its cytoprotective or other biological effect. The first synthesis of H-S-Se-S-H (1.3-dithiatriselane) was reported by Hahn and Klünsch in 1994, but the stability and reactivity in aqueous solution were not investigated. Solid HSSeSH has a melting point at −40°C. It was one component of a mixture of H~2~S~2~Se~n~, prepared by the interaction of 2 H~2~S with Se~2~Cl~2~ \[[@B60]\].

The EPR data ([Figure 5](#fig5){ref-type="fig"}) once more confirm that SeO~3~^2−^ on its own is not an antioxidant; it becomes activated by *reduction*, for instance, by H~2~S, which concurrently is activated by *oxidation*. The mutual redox activation is fast, and, as in the case of the ^·^cPTIO radical scavenging, the pristine mixture of H~2~S and SeO~3~^2−^ is most active, with a decrease of activity over the time, pointing once more at simple H~2~S*~x~* or H~2~S*~x~*Se, and notably HSSeSH, but not an S*~x~*Se*~y~*, as being responsible for this kind of activity.

We found that the products of this described H~2~S/SeO~3~^2−^ interaction have several noteworthy biological effects, involving ROS scavenging, modulation of the redox state, reaction with DNA, tensing isolated aorta, and influencing BP and pulse BP (Figures [6](#fig6){ref-type="fig"}[](#fig7){ref-type="fig"}--[8](#fig8){ref-type="fig"}). These effects obviously need to be investigated further and in considerably more detail and were not present or were less pronounced when H~2~S or selenite acted alone. The properties of the products of the H~2~S/SeO~3~^2−^ interactions significantly depended on the H~2~S/SeO~3~^2−^ molar ratio, pH, and preincubation time. The combination of these variables makes the work with H~2~S/SeO~3~^2−^ very complicated, and these facts should be taken into account at the time of designing *in vitro* and *in vivo* experiments. These properties of the products may explain the previously published beneficial and contrasting toxic Se effects, for example, in conditions of oxidative stress and cancer \[[@B12]--[@B14], [@B18], [@B20], [@B22], [@B23], [@B30]\].

H~2~S is endogenously produced *in vivo* in most, if not in all, cells, and H~2~S donors are commonly used in biological experiments, and they are considered to be applied in medicine. Our results suggest that in biological experiments with selenite, in its nutrition supplement and clinical use, effects of the H~2~S/SeO~3~^2−^ interaction should be considered. While SeO~3~^2−^ is used widely as a nutritional supplement already, one may, in the future, wish to spice it up with some reduced sulfur. Natural spices such as garlic and onions contain suitable sulfide releasing agents, such as diallyltrisulfide (DATS) and diallyltetrasulfide (DATTS), which both occur naturally in garlic, or dipropyltrisulfide and dipropyltetrasulfide, both present in onions \[[@B61]\]. Our results imply that application research of suitable H~2~S/SeO~3~^2−^ supplements may lead to the beneficial effects in pathological conditions arising, e.g., from ROS overproduction.
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BMPO:
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BP:
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^·^cPTIO:

:   2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

DTPA:

:   Diethylenetriaminepentaacetic acid

EPR:

:   Electron paramagnetic resonance

H~2~S:

:   Hydrogen sulfide

H~2~O~2~:

:   Hydrogen peroxide

i.p.:

:   Intraperitoneal
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:   Intravenous
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:   Noradrenaline
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:   Plasmid DNA

SeCl~4~:

:   Selenium tetrachloride
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![Interaction of ^·^cPTIO/SeO~3~^2−^ with H~2~S. (a) Time resolved UV-VIS spectra of the interaction of 100 *μ*mol L^−1\ ·^cPTIO with 100 *μ*M SeO~3~^2−^ (3 times repeated every 30 s, black) and subsequent addition of 100 *μ*mol L^−1^ H~2~S. Spectra were collected every 30 s for 15 min; the first spectrum, indicated by the solid red line, was measured 15 s after addition of H~2~S. Top inset: kinetics of changes in absorbance at 560 nm after addition of 100 *μ*mol L^−1^ H~2~S into ^·^cPTIO/SeO~3~^2−^ (100/100 in *μ*mol L^−1^) solution at time 0 s. Bottom inset: details of the time resolved spectra of the ^·^cPTIO/SeO~3~^2−^ (100/100 in *μ*mol L^--1^) interaction before (black) and after addition of H~2~S (100 *μ*mol L^−1^, the first spectrum is indicated by the solid red line, which is followed each 30 s by: long dash red, medium dash red, short dash red, dotted red, solid blue line, long dash blue, medium dash blue, etc.). (b, c, d, e) H~2~S (100 *μ*mol L^−1^) was added to 100 *μ*mol L^−1^ solution of ^·^cPTIO containing different concentrations of SeO~3~^2−^ (0-400 *μ*mol L^−1^, see legend). The kinetics of the reduction of 100 *μ*mol L^−1\ ·^cPTIO before and after addition of 100 *μ*mol L^−1^ H~2~S (marked by arrow) was monitored as a decrease of the absorbance at 358 nm minus the absorbance at 420 nm (b, d) and also as a decrease of the absorbance at 560 nm (c, e).](OMCL2019-9847650.001){#fig1}

![Effect of the SeO~3~^2−^ and H~2~S concentration on the reduction of ^·^cPTIO. (a) Effect of the SeO~3~^2−^ concentration (1-400 *μ*mol L^−1^) on the reduction of ^·^cPTIO (100 *μ*mol L^−1^) in the presence of H~2~S (100 *μ*mol L^−1^). Arrow indicates the 1 : 4 molar ratio of SeO~3~^2−^ : H~2~S. (b) Effect of the H~2~S concentration (0-200 *μ*mol L^−1^) on the reduction of ^·^cPTIO (100 *μ*mol L^−1^) in the presence of SeO~3~^2−^ (100 *μ*mol L^−1^). The reduction of ^·^cPTIO was evaluated as the decrease of the absorbance at 560 nm after 2.25 min of the reaction (pH 7.4, 37°C). All values represent the means ± S.E.M., *n* = 2‐4.](OMCL2019-9847650.002){#fig2}

![Effect of pH on the reduction of ^·^cPTIO in the presence of SeO~3~^2−^ induced by H~2~S. Time resolved UV-VIS spectra of the interaction of H~2~S (100 *μ*mol L^−1^ final) with ^·^cPTIO/SeO~3~^2−^ (100/50 in *μ*mol L^−1^ final) at pH 6.5 (a), 7.0 (b), 7.4 (c), 8.0 (d), and 9.0 (e). The first spectrum was recorded 15 s after H~2~S addition (solid red line) followed each 30 s by: long dash red, medium dash red, short dash red, dotted red, solid blue line, long dash blue, medium dash blue, etc. Samples were measured every 30 s for 20 min. The black line represents the spectrum of ^·^cPTIO/SeO~3~^2−^ before the H~2~S addition. (f) Dependence of ^·^cPTIO (100 *μ*mol L^−1^) reduction by H~2~S/SeO~3~^2−^ (100/50 in *μ*mol L^−1^) on pH. Data were taken from the spectra shown in (a), (b), (c), (d), and (e) as a minimum of A~560~ in the range of 0-4 min. The buffers consisted of 100 mmol L^−1^ sodium phosphate, 100 *μ*M DTPA, 37°C, and pH values were adjusted to desired pH.](OMCL2019-9847650.003){#fig3}

![Influence of the preincubation time of the H~2~S/SeO~3~^2−^ mixture on the time-dependent reduction of ^·^cPTIO. The reduction of ^·^cPTIO (100 *μ*mol L^−1^) once added into the preincubated H~2~S/SeO~3~^2−^ mixture (100/50 in *μ*mol L^−1^, (a, b); 100/100 in *μ*mol L^−1^ (c, d)) was evaluated as the decrease of absorbance at 358 nm minus 420 nm (a, c) and the decrease of absorbance at 560 nm (b, d), respectively. The preincubation time of the H~2~S/SeO~3~^2−^ mixture was 0-40 min (see legend). (e) Impact of the preincubation time of the H~2~S/SeO~3~^2−^ mixture on the reduction of ^·^cPTIO. ^·^cPTIO (100 *μ*M) was added into preincubated H~2~S/SeO~3~^2−^ (in *μ*mol L^−1^, 100/100, circles; 100/50, triangles; 100/25, diamonds) at pH 7.4, 37°C. Data represent the reduction of ^·^cPTIO in 1^st^ minute after addition of ^·^cPTIO.](OMCL2019-9847650.004){#fig4}

![EPR spectra of ^·^BMPO in the presence of O~2~^·−^ are modulated by H~2~S/SeO~3~^2−^. Representative EPR spectra of the ^·^BMPO adducts were monitored in 10% *v*/*v* saturated KO~2~/DMSO solution in 50 mmol L^−1^ sodium phosphate buffer, 0.1 mmol L^−1^ DTPA, pH 7.4, 37°C in the presence of the various investigated chalcogen species and 20 mmol L^−1^ BMPO. Sets of individual EPR spectra of the ^·^BMPO adducts monitored upon 15 sequential scans, each 42 s (a1-h1), starting acquisition 2 min after sample preparation in: control 10% *v*/*v* KO~2~/DMSO in the buffer (a1), the KO~2~/DMSO in the presence of 25 *μ*mol L^−1^ SeO~3~^2−^ (b1), 25 *μ*mol L^−1^ H~2~S (c1), mixture of 25/25 in *μ*mol L^−1^ H~2~S/SeO~3~^2−^ (d1), 25/25 in *μ*mol L^−1^ H~2~S/SeO~3~^2−^ preincubated 5 min before KO~2~/DMSO stock solution addition (e1), 50 *μ*mol L^−1^ H~2~S (f1), mixture of 50/25 in *μ*mol L^−1^ H~2~S/SeO~3~^2−^ (g1), and 50/25 in *μ*mol L^−1^ H~2~S/SeO~3~^2−^ preincubated 5 min before addition of KO~2~/DMSO stock solution (h1). The spectra (a2-h2) show details of the accumulated first ten spectra of the (a1-h1) sets. The intensities of the time-dependent EPR spectra (a1-h1) and detailed spectra (a2-h2) are comparable; they were measured under identical EPR settings. EPR modulation amplitude 0.15 mT. (a3-h3) Comparison of the integral intensity of individual components of simulated BMPO+O~2~^·−^ without (control) and with chalcogen species shown in (a1-h1). The first five EPR spectra were accumulated and used for simulation. The data represent the means of *n* = 2; standard error was ≤10% of the mean value. Simulated relative intensities of the two conformers of the radicals: ^·^BMPO-OOH1 (black), ^·^BMPO-OOH2 (red), ^·^BMPO-OH1 (green), ^·^BMPO-OH2 (yellow), and ^·^BMPO-C (blue).](OMCL2019-9847650.005){#fig5}

![The influence of H~2~S/SeO~3~^2−^ on pDNA cleavage in the absence and presence of H~2~O~2~ and DMSO. Representative gels (a1, b1) and column graphs (a2, b2) indicating the effects of increasing concentrations of SeO~3~^2−^ (0-1 mmol L^−1^) on pDNA cleavage in the presence of 1 mmol L^−1^ H~2~S, without (a1, a2) and with 1 mmol L^−1^ H~2~O~2~ (b1, b2). The band at the bottom corresponds to the circular supercoiled form of pDNA, and the less intense band appearing above, in the case of Fe^2+^-H~2~O~2~, represents the linear form of pDNA. The top band corresponds to the nicked circular form of pDNA. The effects of 150 *μ*mol L^−1^ FeCl~2~ + 1 mmol L^−1^ H~2~O~2~ (full column) are shown for comparison. Values are the means ± S.E.M., *n* = 3. Representative gels (c1) and column graph (c2) showing the effects of increasing concentrations of DMSO on H~2~S/SeO~3~^2−^ (0.25/1 in mmol L^−1^)-induced pDNA cleavage. DMSO concentrations: 1 × 10^−4^% (*v*/*v*) DMSO = 14.1 *μ*mol L^−1^ DMSO; 1 × 10^−3^% = 141 *μ*mol L^−1^; 1 × 10^−2^% = 1.41 mmol L^−1^; 1 × 10^−1^% = 14.1 mmol L^−1^; 1 × 10^0^% = 141 mmol L^−1^. Values represent means ± S.E.M., *n* = 4.](OMCL2019-9847650.006){#fig6}

![Time-dependent tonus of isolated thoracic aorta. The original records of changes in NA (1 *μ*mol L^−1^)-increased arterial tone of isolated rat thoracic aorta after addition of SeO~3~^2−^ (100 *μ*mol L^−1^), H~2~S (200 *μ*mol L^−1^), and H~2~S/SeO~3~^2−^ (200/100 in *μ*mol L^−1^) mixture. The arrow indicates the compound application (a). The effects of SeO~3~^2−^, H~2~S, and H~2~S/SeO~3~^2−^ on NA (1 *μ*mol L^−1^)-precontracted rings of rat thoracic aorta. The rings were exposed to bolus dose of H~2~S (200 *μ*mol L^−1^, relaxation), SeO~3~^2−^ (100 *μ*mol L^−1^, nonsignificant contraction), and that of the mixture H~2~S/SeO~3~^2−^ (100 *μ*mol L^−1^ of SeO~3~^2−^ immediately followed by 200 *μ*mol L^−1^ H~2~S). The SeO~3~^2−^/H~2~S mixture had a biphasic activity; firstly, it significantly relaxed the aorta, which was followed by significant contraction (b). Asterisks mark the statistical significance of H~2~S/SeO~3~^2−^ mixture vs. H~2~S (^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001).](OMCL2019-9847650.007){#fig7}

![The time-dependent effects of SeO~3~^2−^, H~2~S, and H~2~S/SeO~3~^2−^ on rat BP and pulse BP. Representative traces of the time-dependent effect of i.v. bolus administration of H~2~S (10 *μ*mol kg^−1^; (a, d)) and its mixture with 5 *μ*mol kg^−1^ SeO~3~^2−^ prepared at pH \~ 7.4 (b, e) and pH \~ 11 (c, f) solution on BP (a, b, c) and pulse BP (d, e, f). Transient changes of rat BP (g) and pulse BP (h) after i.v. bolus administration of SeO~3~^2−^ (5 *μ*mol kg^−1^, empty column), H~2~S (10 *μ*mol kg^−1^, empty coarse column) and their mixture (SeO~3~^2−^/H~2~S, 5/10 in *μ*mol kg^−1^) prepared at pH \~ 7.4 (grey column) and pH \~ 11 (grey coarse column). Data are presented as means ± SD; *n* = 5‐10. To test a statistical significance between group differences, we used one-way ANOVA followed by Dunnett\'s test for multiple comparisons. Hence, we also observed the biphasic effect of Na~2~S in our previous study \[[@B54]\]; we compared a set of "first part" and "second part" effects of SeO~3~^2−^, H~2~S/SeO~3~^2−^ at pH \~ 7.4, and H~2~S/SeO~3~^2−^ at pH \~ 11.0 to the corresponding effect of Na~2~S on systolic or pulse blood pressure. Only the mixture of H~2~S/SeO~3~^2−^ prepared at pH \~ 11.0 was able to generate similar decrease and subsequent increase or *vice versa* in systolic blood pressure or pulse blood pressure as the H~2~S, respectively. Asterisks mark the statistical significance as follows: ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001, and ^∗∗∗∗^*P* \< 0.0001.](OMCL2019-9847650.008){#fig8}
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